Work Here?
Overview
Eupry provides temperature and humidity monitoring for regulated industries using Wi-Fi data loggers and a SaaS platform to continuously track environmental conditions, alert on deviations, and maintain audit trails. Readings from the data loggers are sent to the cloud where the software analyzes them and shows dashboards, with real-time alerts and regulatory records. The system emphasizes GxP and FDA 21 CFR Part 11 compliance through a centralized, auditable data history and bundled calibration and mapping in a single subscription. Its goal is to help customers stay compliant, protect sensitive products, and reduce time and cost of monitoring and audits.
About Eupry
Industries
Hardware
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$28.8M
Headquarters
Copenhagen, Denmark
Founded
2014
Get referred to Eupry
See people who can refer or advise you
Simplify's Take
What believers are saying
- On 2026-09-09, Eupry updated a €2.4m investment announcement, signaling ongoing investor support.
- 2026 regulatory tightening around EU Annex 11 and FDA Part 11 favors compliant incumbents.
- The 2024-12 Series A, over DKK170 million, funds product development and U.S. scaling.
What critics are saying
- Dantherm, DeltaTrak, and Rees Scientific compete directly on regulated temperature monitoring.
- Eupry's narrow pharma focus limits expansion if compliance software budgets freeze in 2027.
- U.S. expansion funded by EIFO and 2024 Series A demands rapid execution; misses crush valuation.
What makes Eupry unique
- Eupry unifies wireless monitoring, validation, and calibration for GxP workflows.
- Its FDA 21 CFR Part 11 module and audit-ready reports target regulated buyers.
- A 2026 DTU review shows customers using Eupry across multiple devices simultaneously.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$28.8M
Above
Industry Average
Funded Over
4 Rounds
Industry standards
Benefits
Health Insurance
Dental Insurance
Paid Vacation
Paid Sick Leave
Flexible Work Hours
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 2%1 year growth
↑ 2%2 year growth
↑ 0%Copenhagen-based startup Eupry has secured €23M in A-round funding, led by Chr. Augustinus Fabrikker, with support from Ugly Duckling Ventures, the Export and Investment Fund of Denmark, and the Sagitta Family Office. The funding will accelerate product development and global expansion, particularly in the U.S. Eupry aims to enhance its temperature monitoring solutions for industries like pharmaceuticals and logistics. CEO Christian Jacobsen expressed gratitude to the investors for their support.
Eupry, a Danish medtech company, secured a DKK170 million Series A investment led by new investor Chr. Augustinus Fabrikker, with participation from existing investors Ugly Duckling Ventures, EIFO, and Sagitta Family Office. The funding will support Eupry's product development and expansion in the U.S. market, addressing global demand for precise temperature control in the pharmaceutical industry. CEO Christian Jacobsen expressed gratitude for the continued support from their investor group.
The Danish entrepreneurial company Eupry has entered into a multi-year collaborative agreement with DTU Vet.
Copenhagen-born SaaS company Eupry has collected 2.4 million euros from the Danish Growth Fund and Ugly Duckling Ventures. Started out as a collaborative
Eupry is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Eupry
Industries
Hardware
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$28.8M
Headquarters
Copenhagen, Denmark
Founded
2014
Eupry is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today